Effects xamoterol inotropic lusitropic properties human myocardium adenylate cyclase activity purpose present study effects xamoterol human myocardium presence forskolin milrinone xamoterol isometric force contraction contraction velocity relaxation velocity isolated driven preparations human myocardium effect difference effect xamoterol right atrial myocardium ventricular myocardium NF NYHA II-III NYHA IV human hearts positive inotropic lusitropic effects isoprenaline severity heart failure left ventricular myocardium NF NYHA II-III NYHA IV presence norepinephrine xamoterol negative inotropic effects similar beta-adrenoceptor antagonists effects force contraction whereas pindolol propranolol contractile force NYHA class IV isoprenaline adenylate cyclase twofold xamoterol pindolol propranolol effect Experiments beta beta antagonists CGP ICI positive inotropic lusitropic effects xamoterol beta xamoterol selectivity beta radioligand binding experiments xamoterol acts beta antagonist selectivity human ventricular myocardium compound intrinsic sympathomimetic activity beta positive inotropic lusitropic effects presence forskolin beneficial effects xamoterol patients heart failure due prevention detrimental effects norepinephrine beta downregulation increase Gi inhibitory guanine-nucleotide binding protein 